Keya Basu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Keya Basu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Abhishek De
Department of Dermatology, Calcutta National Medical College and Hospital, Kolkata, West Bengal, India
2 shared publications - Himadri Nath
CSIR-Indian Institute of Chemical Biology
2 shared publications - Sohini Parveen Sarwala
Department of Nephropathology, Institute of Post Graduate Medical Education and Research (IPGME&R) SSKM Hospital, Kolkata, India
2 shared publications - Subhajit Biswas
Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Jadavpur, Kolkata-700032, Wet Bengal, India
2 shared publications - Subhrajyoti Karmakar
Department of Nephropathology, Institute of Post Graduate Medical Education and Research (IPGME&R) SSKM Hospital, Kolkata, India
2 shared publications - Abinash Mallick
Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Jadavpur, Kolkata-700032, Wet Bengal, India
1 shared publication
Latest Publications
- Open Access
- 22 May 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Diagnostic challenge of postrenal transplant polyomavirus nephropathy with varied presentations: a case series
Sohini Parveen Sarwala, Subhrajyoti Karmakar, Keya Basu, Koushik Bhattacharjee. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0053
- 22 May 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Open AccessDiagnostic challenge of postrenal transplant polyomavirus nephropathy with varied presentations: a case series
Sohini Parveen Sarwala, Subhrajyoti Karmakar, Keya Basu, Koushik Bhattacharjee. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0053
- Open Access
- 30 May 2025
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 13 (6) , 2637-2639
Unravelling the cardiac conundrum of amyloidosis: an experience from a tertiary care centre
Amyloidosis encompasses a spectrum of diseases caused due to extracellular deposition of misfolded proteins in body. The most common subtypes that infiltrate cardiac tissue are AL, ATTRwt (wild type), ATTRv (mutated) and Isolated atrial amyloidosis. Here, we elaborate such an interesting case of cardiac AL amyloidosis. A 69-year-old male presented with shortness of breath and restrictive cardiomyopathy. Further endomyocardial biopsy showed acellular, light eosinophilic deposit. Direct immunofluorescence showed lambda light chain restriction, concordant with elevated serum free λ light chain level. Finally, positive Congo red stain with apple green birefringence under polarised light clinched the diagnosis of Cardiac AL Amyloidosis. Endomyocardial biopsy with congo red stain and immunofluorescence is indispensable for diagnosis and subtyping of AL amyloidosis. This sets apart other amyloid subtypes and cardiac light chain deposition disease. Early diagnosis of cardiac amyloidosis subtype is imperative to guide the therapy and evaluate the prognosis of the patient.
- 30 May 2025
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 13 (6) , 2637-2639
Open AccessUnravelling the cardiac conundrum of amyloidosis: an experience from a tertiary care centre
Amyloidosis encompasses a spectrum of diseases caused due to extracellular deposition of misfolded proteins in body. The most common subtypes that infiltrate cardiac tissue are AL, ATTRwt (wild type), ATTRv (mutated) and Isolated atrial amyloidosis. Here, we elaborate such an interesting case of cardiac AL amyloidosis. A 69-year-old male presented with shortness of breath and restrictive cardiomyopathy. Further endomyocardial biopsy showed acellular, light eosinophilic deposit. Direct immunofluorescence showed lambda light chain restriction, concordant with elevated serum free λ light chain level. Finally, positive Congo red stain with apple green birefringence under polarised light clinched the diagnosis of Cardiac AL Amyloidosis. Endomyocardial biopsy with congo red stain and immunofluorescence is indispensable for diagnosis and subtyping of AL amyloidosis. This sets apart other amyloid subtypes and cardiac light chain deposition disease. Early diagnosis of cardiac amyloidosis subtype is imperative to guide the therapy and evaluate the prognosis of the patient.
- Open Access
- 10 June 2021
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 70 (6) , 001369
Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests
Co-endemicity of SARS-CoV-2 and dengue virus (DV) infection is becoming a matter of serious concern as it has been already reported that antibodies (Ab) elicited by SARS-CoV-2 infection can produce false-positive results in dengue IgG and IgM rapid tests and vice versa. Here we communicate that five of thirteen DV antibody-positive serum samples from Kolkata, archived in 2017 (predating the COVID-19 outbreak), produced false-positive results in SARS-CoV-2 IgG/IgM lateral flow-based rapid tests. Our results emphasize the importance of implementing tests with higher specificity to conduct sero-surveillance for accurate estimation of SARS-CoV-2/DV prevalence in regions where both viruses now co-exist.
- 10 June 2021
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 70 (6) , 001369
Open AccessArchived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests
Co-endemicity of SARS-CoV-2 and dengue virus (DV) infection is becoming a matter of serious concern as it has been already reported that antibodies (Ab) elicited by SARS-CoV-2 infection can produce false-positive results in dengue IgG and IgM rapid tests and vice versa. Here we communicate that five of thirteen DV antibody-positive serum samples from Kolkata, archived in 2017 (predating the COVID-19 outbreak), produced false-positive results in SARS-CoV-2 IgG/IgM lateral flow-based rapid tests. Our results emphasize the importance of implementing tests with higher specificity to conduct sero-surveillance for accurate estimation of SARS-CoV-2/DV prevalence in regions where both viruses now co-exist.
- Open Access
Dengue virus clinical isolates sustain viability of infected hepatic cells by counteracting apoptosis-mediated DNA breakage
NS1, a virotoxin, abundantly present in Dengue patients’ blood, is a major player behind disease patho-biogenesis including plasma leakage and damage to the liver. Despite the presence of NS1 in blood, Dengue is asymptomatic and self-limiting in ≥80% Dengue virus (DV) infected people. We investigated this observation and found that plasmid-mediated NS1 expression and secretion in liver cells (Huh7) are sufficient to cause programmed cell death (apoptosis) and associated cellular DNA breakage. However, liver or kidney cell lines infected with DV and secreting equivalent amounts of NS1 didn’t exhibit apoptotic DNA breakage. In fact, DV-infected cells showed better survival than cells in which only NS1 was transiently expressed by transfection. We also found that DV can even prevent chemical-induced apoptotic DNA damage in infected host cells. So, DV thwarts host antiviral defence i.e. apoptosis, by counteracting cellular DNA breakages and keeps the infected cells metabolically active to prolong virus replication.
Open AccessDengue virus clinical isolates sustain viability of infected hepatic cells by counteracting apoptosis-mediated DNA breakage
NS1, a virotoxin, abundantly present in Dengue patients’ blood, is a major player behind disease patho-biogenesis including plasma leakage and damage to the liver. Despite the presence of NS1 in blood, Dengue is asymptomatic and self-limiting in ≥80% Dengue virus (DV) infected people. We investigated this observation and found that plasmid-mediated NS1 expression and secretion in liver cells (Huh7) are sufficient to cause programmed cell death (apoptosis) and associated cellular DNA breakage. However, liver or kidney cell lines infected with DV and secreting equivalent amounts of NS1 didn’t exhibit apoptotic DNA breakage. In fact, DV-infected cells showed better survival than cells in which only NS1 was transiently expressed by transfection. We also found that DV can even prevent chemical-induced apoptotic DNA damage in infected host cells. So, DV thwarts host antiviral defence i.e. apoptosis, by counteracting cellular DNA breakages and keeps the infected cells metabolically active to prolong virus replication.